Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
Go back to Context Therapeutics Reports First Quarter 2026 Operating and Financial Results| (NASDAQ: CNTX) | Delayed: 0.65 +0.02 (3.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.63 | 52 Week High | $ | |||
| Open | $0.60 | 52 Week Low | $ | |||
| Day High | $0.70 | P/E | N/A | |||
| Day Low | $0.59 | EPS | $ | |||
| Volume | 3,189,153 | |||||

